Anika Therapeutics, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Anika Therapeutics, Inc. (ANIK) had Deferred Tax Assets, Goodwill and Intangible Assets of $776.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-03-03
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $776.00K.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $5.96M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $5.42M; Deferred Tax Assets, Goodwill and Intangible Assets as first filed $5.04M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $0.00.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets | Deferred Tax Assets, Goodwill and Intangible Assets as first filed |
|---|---|---|
| 2025-12-31 | $776.00K 10-K · filed 2026-03-03 | |
| 2024-12-31 | $5.96M 10-K · filed 2026-03-03 | |
| 2023-12-31 | $5.42M 10-K · filed 2025-03-17 | $5.04M 10-K · filed 2024-03-15 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |